Absorption |
Blood-Brain Barrier | BBB- | 0.9026 |
Human Intestinal Absorption | HIA+ | 0.9464 |
Caco-2 Permeability | Caco2- | 0.7305 |
P-glycoprotein Substrate | Substrate | 0.7596 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8011 |
Non-inhibitor | 0.5135 |
Renal Organic Cation Transporter | Non-inhibitor | 0.6511 |
Distribution |
Subcellular localization | Mitochondria | 0.8136 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8014 |
CYP450 2D6 Substrate | Non-substrate | 0.7951 |
CYP450 3A4 Substrate | Non-substrate | 0.5827 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.6669 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9295 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8282 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9358 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.7648 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9401 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Strong inhibitor | 0.6306 |
Inhibitor | 0.7594 |
AMES Toxicity | Non AMES toxic | 0.7687 |
Carcinogens | Non-carcinogens | 0.9430 |
Fish Toxicity | High FHMT | 0.8782 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9056 |
Honey Bee Toxicity | Low HBT | 0.6340 |
Biodegradation | Not ready biodegradable | 0.5579 |
Acute Oral Toxicity | III | 0.6356 |
Carcinogenicity (Three-class) | Non-required | 0.7643 |